6,150 reports of this reaction
4.9% of all Ocrevus reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for Ocrevus, manufactured by Genentech, Inc.. There are 6,150 FDA adverse event reports linking Ocrevus to FATIGUE. This represents approximately 4.9% of all 124,640 adverse event reports for this drug.
Patients taking Ocrevus who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among Ocrevus users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for Ocrevus:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 6,150 FDA reports for Ocrevus. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.9% of all adverse event reports for Ocrevus, making it one of the most commonly reported side effect.
If you experience fatigue while taking Ocrevus, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.